Institutional Manager · CIK 0001778253
Ikarian Capital, LLC
DALLAS, TX · File #028-19721
Latest AUM
$1.28B
Positions
174
Top-10 Concentration
48.6%
Filings
10
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | AMGEN INC | AMGN | +200,000 | +$65.5M | $0 |
| ADD | TERNS PHARMACEUTICALS INC | TERN | +1,432,176 | +$57.9M | +$5.4M |
| EXITED | GENMAB A/S | 372303206 | -175,000 | -$53.0M | $0 |
| REDUCE | ABIVAX SA | AAVXF | -270,998 | -$36.5M | +$20.0M |
| EXITED | BRISTOL-MYERS SQUIBB CO | 110122108 | -800,000 | -$36.1M | $0 |
| EXITED | SCHOLAR ROCK HLDG CORP | 80706P103 | -561,600 | -$20.9M | $0 |
| ADD | VAXCYTE INC | PCVX | +371,682 | +$17.1M | +$70,840 |
| ADD | JAZZ PHARMACEUTICALS PLC | JAZZ | +99,300 | +$16.9M | +$2.7M |
| ADD | SOLENO THERAPEUTICS INC | SLNO | +352,800 | +$16.3M | -$3.8M |
| NEW | OMEROS CORP | OMER | +950,000 | +$16.3M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 2025174 pos · $1.28B
- 13F HOLDINGS REPORTQ/E Sep 2025169 pos · $990.4M
- 13F HOLDINGS REPORTQ/E Jun 2025133 pos · $520.6M
- 13F HOLDINGS REPORTQ/E Mar 2025160 pos · $811.5M
- 13F HOLDINGS REPORTQ/E Dec 2024171 pos · $735.3M
- 13F HOLDINGS REPORTQ/E Sep 2024145 pos · $717.2M
- 13F HOLDINGS REPORTQ/E Jun 2024130 pos · $574.1M
- 13F HOLDINGS REPORT (Amended)Q/E Mar 2024137 pos · $912.0M
- 13F HOLDINGS REPORTQ/E Mar 2024138 pos · $959.3M
- 13F HOLDINGS REPORTQ/E Dec 2023140 pos · $831.4M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | SPDR SERIES TRUST | 78464A870 | 850,000 | $103.6M | 10.13% |
| 2 | CIDARA THERAPEUTICS INC | 171757206 | 300,000 | $66.3M | 6.48% |
| 3 | AMGEN INC | AMGN | 200,000 | $65.5M | 6.40% |
| 4 | TERNS PHARMACEUTICALS INC | TERN | 1,596,378 | $64.5M | 6.30% |
| 5 | CIDARA THERAPEUTICS INC | 171757206 | 273,243 | $60.4M | 5.90% |
| 6 | ABIVAX SA | AAVXF | 205,985 | $29.1M | 2.85% |
| 7 | JAZZ PHARMACEUTICALS PLC | JAZZ | 170,000 | $28.9M | 2.82% |
| 8 | JAZZ PHARMACEUTICALS PLC | JAZZ | 160,367 | $27.3M | 2.66% |
| 9 | MAZE THERAPEUTICS INC | MAZE | 644,680 | $26.7M | 2.61% |
| 10 | PRAXIS PRECISION MEDICINES I | PRAX | 86,581 | $25.5M | 2.49% |
| 11 | HARROW INC | HROW | 509,700 | $25.0M | 2.44% |
| 12 | SOLENO THERAPEUTICS INC | SLNO | 528,900 | $24.5M | 2.39% |
| 13 | RAPT THERAPEUTICS INC | 75382E208 | 665,271 | $22.5M | 2.20% |
| 14 | KODIAK SCIENCES INC | KOD | 719,787 | $20.1M | 1.97% |
| 15 | OLEMA PHARMACEUTICALS INC | OLMA | 758,654 | $19.0M | 1.85% |
| 16 | CYTOKINETICS INC | CYTK | 290,900 | $18.5M | 1.81% |
| 17 | VAXCYTE INC | PCVX | 378,682 | $17.5M | 1.71% |
| 18 | CRINETICS PHARMACEUTICALS IN | CRNX | 368,500 | $17.2M | 1.68% |
| 19 | ABIVAX SA | AAVXF | 125,100 | $16.9M | 1.65% |
| 20 | CAPRICOR THERAPEUTICS INC | CAPR | 578,015 | $16.7M | 1.63% |